Literature DB >> 7522058

Successful treatment of chronic wound infection in neutropenia and rheumatoid arthritis with filgrastim (rhG-GSF)

J Fohlman1, M Höglund, S Bergmann.   

Abstract

A 73-year-old woman was diagnosed with seropositive destructive rheumatoid arthritis in 1981. She was treated with cortisone, chloroquine, and cyclophosphamide (Sendoxan) in 1982 and 1984 and contracted severe neutropenia. After that she only received cortisone. During 1991, again low neutrophilic counts were registered, especially granulocytopenia. At first, B-cell lymphoma was suspected, but later Felty's syndrome was established. The patient was treated with high-dose cortisone with some success and had a few minor septic episodes. In May 1992 she contracted a traumatic wound on the back of the lower leg. Conservative treatment resulted in a worsening of the condition and an increased wound area, most likely related to the neutropenic condition. In mid July the patient was hospitalized. Bacterial isolates yielded mixed gram-negative enteric bacteria from the wound. Parenteral antibiotic treatment was started, followed by oral drugs, rhG-CSF (filgrastim) was given subcutaneously once a day, starting 3 days after admission. This resulted in increased numbers of peripheral granulocytes. The ulcer started to heal and by mid August the patient received a transplant with autologous skin grafting. In mid September the wound was completely healed. It is concluded that the combination of antibiotics, skin transplantation, and G-CSF was necessary for the successful result. Actually, the bacterial growth did not call for antibiotics, but it was considered necessary to cover for staphylococci. No worsening of the underlying arthritis was observed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7522058     DOI: 10.1007/bf01695698

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  16 in total

1.  Depressed superoxide radical generation by neutrophils from patients with rheumatoid arthritis and neutropenia: correlation with neutrophil reactive IgG.

Authors:  P Davis; C Johnston; J Bertouch; G Starkebaum
Journal:  Ann Rheum Dis       Date:  1987-01       Impact factor: 19.103

2.  Correction of granulocytopenia in Felty's syndrome by granulocyte-macrophage colony-stimulating factor. Simultaneous induction of interleukin-6 release and flare-up of the arthritis.

Authors:  B P Hazenberg; M A Van Leeuwen; M H Van Rijswijk; A C Stern; E Vellenga
Journal:  Blood       Date:  1989-12       Impact factor: 22.113

3.  HLA-DRw4 in Felty's syndrome.

Authors:  H J Dinant; W Hissink Muller; E M van den Berg-Loonen; L E Nijenhuis; C P Engelfriet
Journal:  Arthritis Rheum       Date:  1980-11

4.  Felty syndrome.

Authors:  J Goldberg; R S Pinals
Journal:  Semin Arthritis Rheum       Date:  1980-08       Impact factor: 5.532

Review 5.  Recombinant granulocyte colony-stimulating factor (rG-CSF). A review of its pharmacological properties and prospective role in neutropenic conditions.

Authors:  L M Hollingshead; K L Goa
Journal:  Drugs       Date:  1991-08       Impact factor: 9.546

6.  Improvement of pneumonia and arthritis in Felty's syndrome by treatment with granulocyte-macrophage colony-stimulating factor (GM-CSF).

Authors:  A S Lübbe; N Schwella; H Riess; D Huhn
Journal:  Blut       Date:  1990-12

7.  Heterogeneity of bone marrow-directed immune mechanisms in the pathogenesis of neutropenia of Felty's syndrome.

Authors:  N I Abdou
Journal:  Arthritis Rheum       Date:  1983-08

8.  Successful reversal of neutropenia in Felty's syndrome with recombinant granulocyte colony stimulating factor.

Authors:  M F Choi; M J Mant; A R Turner; J J Akabutu; S L Aaron
Journal:  Br J Haematol       Date:  1994-03       Impact factor: 6.998

9.  Factors influencing the incidence of infections in Felty's syndrome.

Authors:  F C Breedveld; W E Fibbe; J Hermans; J W van der Meer; A Cats
Journal:  Arch Intern Med       Date:  1987-05

10.  Cytokines in chronic inflammatory arthritis. IV. Granulocyte/macrophage colony-stimulating factor-mediated induction of class II MHC antigen on human monocytes: a possible role in rheumatoid arthritis.

Authors:  J M Alvaro-Gracia; N J Zvaifler; G S Firestein
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

View more
  1 in total

Review 1.  An update on drug-induced arthritis.

Authors:  Marwan H Adwan
Journal:  Rheumatol Int       Date:  2016-03-21       Impact factor: 2.631

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.